Ligand · A7O
A7O · (3-{4-[(4-cyclopropylphenyl)methoxy]-3-methoxyphenyl}azetidin-1-yl)(4-{[(2S)-2,3-dihydroxypropoxy]methyl}pyridin-2-yl)methanone
A7O, (3-{4-[(4-cyclopropylphenyl)methoxy]-3-methoxyphenyl}azetidin-1-yl)(4-{[(2S)-2,3-dihydroxypropoxy]methyl}pyridin-2-yl)methanone (C30 H34 N2 O6, 518.6 g/mol), in the MolNFT structures on GenesisL1: bound in 1 record (1 PDB entry).…
- Component
- A7O
- Formula
- C30 H34 N2 O6
- Class
- ligand
- Structures
- 1
- PDB entries
- 1
Binding sites
A7O in 1 structure; the first of them:
- 6IG8 · Crystal structure of csf-1R kinase domain with a small molecular inhibitor, jte-952 · A7O A1004 · binds TRP550, LEU588, VAL596, ALA614, LYS616, GLU633, MET637, LEU640 and 15 more
Residues it binds most
CYS 1, LEU 1, GLU 1, GLY 1, TYR 1, VAL 1, ALA 1, ASN 1, ASP 1, HIS 1 (residue and the binding sites it lines).
Found with
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.